Holen Sie sich die Stockscreener-App
22.20
4.57%
0.97
Handel nachbörslich:
22.20
Palatin Technologies Inc. Aktie (PTN) Neueste Nachrichten
Dry Eye Disease Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Palatin Technologies, Novaliq, mc2 therapeutics - Barchart.com
PTN Should I Buy - Intellectia AI
Palatin Techs (PTN) Stock Analysis Report | Financials & Insights - Benzinga España
Palatin Technologies (PINK:PTNT) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
Palatin to test 2 obesity-targeting drugs for PWS in clinical trials this year - Prader-Willi Syndrome News
Palatin Technologies Q2 Earnings Call Highlights - Defense World
Palatin Technologies’ Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN) - The Globe and Mail
Palatin Technologies, Inc. (AMEX:PTN) Q2 2026 Earnings Call Transcript - Insider Monkey
Palatin Technologies' Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN) - TradingView
Earnings call transcript: Palatin Technologies Q2 2026 reveals challenges By Investing.com - Investing.com South Africa
Palatin Technologies Inc (PTN) Q2 2026 Earnings Call Highlights: Strategic Advances Amid Rising Losses - GuruFocus
Earnings call transcript: Palatin Technologies Q2 2026 reveals challenges - Investing.com Australia
PTN: Strengthened cash position and advanced rare obesity pipeline with key clinical milestones ahead - TradingView
PALATIN TECHNOLOGIES INC SEC 10-Q Report - TradingView
Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update - The Malaysian Reserve
PTN | Palatin Technologies, Inc. Analyst Forecasts - Quiver Quantitative
PTN | Palatin Technologies, Inc. Insider Trading - Quiver Quantitative
Palatin Technologies Q2 revenue rises yr/yr, net loss widens - TradingView
PTN: MC4R obesity programs advance to clinical trials as cash position strengthens and net loss widens - TradingView
Palatin funds new obesity drug trials for hypothalamic obesity, PWS - Stock Titan
Palantin Technologies to enact 1-for-50 reverse stock split - MSN
Head-To-Head Contrast: Palatin Technologies (PINK:PTNT) vs. Akorn (OTCMKTS:AKRXQ) - Defense World
Calliditas Therapeutics AB (publ) (NASDAQ:CALT) & Palatin Technologies (PINK:PTNT) Critical Analysis - Defense World
Palatin initiated with a Buy at LaidlawRhythm Pharmaceuticals - MSN
The Truth About Palatin Technologies (PTN): Tiny Biotech, Huge Hype – But Is It Worth Your Money? - AD HOC NEWS
Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
Palatin Technologies Targets Hypothalamic Obesity as Next Frontier Beyond GLP-1s (NYSE: PTN) - TradingView — Track All Markets
Here's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock Now - MSN
Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Palatin Technologies (PTNT) Stock Forecast and Price Target 2026 - MarketBeat
Palatin Technologies (PTN) officer reports Form 4 tax-withheld shares - Stock Titan
Palatin Technologies (PTN) CEO Carl Spana details tax share withholdings - Stock Titan
Palatin finishes phase 2 trial in obesity treatment study - MSN
Palatin Technologies (PINK:PTNT) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Palatin Technologies (PTN) CFO/COO reports 565-share insider stock sale - Stock Titan
PTN (PTN) holder plans Rule 144 sale of 565 common shares - Stock Titan
Comparing Clever Leaves (NASDAQ:CLVR) and Palatin Technologies (PINK:PTNT) - Defense World
Palatin Technologies, Inc.(NYSEAM: PTN) added to S&P TMI Index - marketscreener.com
Decliners Report: How Palatin Technologies Inc. (PTN) stock reacts to new regulationsEarnings Miss & Long Hold Capital Preservation Tips - Улправда
Palatin Technologies Earnings Notes - Trefis
How Palatin Technologies Inc. (PTN) stock reacts to new regulationsTrade Risk Assessment & Capital Efficiency Focused Strategies - Улправда
Palatin Technologies Inc trading resumes - MSN
Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
Why Is Palatin Technologies, Inc. (PTN) Stock Up Today? - Meyka
Laidlaw Begins Coverage on Palatin Technologies (NYSEAMERICAN:PTN) - Defense World
JANUS HENDERSON GROUP PLC Acquires Shares in Palatin Technologies Inc - GuruFocus
Palatin Techs (PTN) Receives 'Buy' Rating from Laidlaw & Co. | P - GuruFocus
Laidlaw initiates coverage on Palatin Technologies stock with Buy rating By Investing.com - Investing.com Australia
Laidlaw initiates coverage on Palatin Technologies stock with Buy rating - Investing.com
Palatin Technologies (PTN) executive Wills records vested RSUs and options - Stock Titan
Palatin Technologies (PTN) director awarded new 2011 Plan stock options - Stock Titan
Palatin Technologies (PTN) CEO logs RSU vesting and option awards after 18‑month performance period - Stock Titan
[Form 4] PALATIN TECHNOLOGIES INC Insider Trading Activity - Stock Titan
Why Are Palatin Technologies (PTN) Shares Spiking After-Hours? - Benzinga
Critical Survey: NexImmune (NASDAQ:NEXI) and Palatin Technologies (PINK:PTNT) - Defense World
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):